Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V for the active ingredient cyclosporine, ATC S01XA18 for the period 01.04.2025 - 31.03.2027
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ciclosporin, ATC S01XA18 für die Zeit 01.04.2025 - 31.03.2027
Germany · Hamburg
Contract
BuyerDAK-Gesundheit
TypeSupplies
Estimated value1 €
Published17 February 2025
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Abacus Medicine A/S · Kopenhagen | 172 | 2022–2026 |
| kohlpharma GmbH · Merzig | 157 | 2022–2026 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 126 | 2022–2026 |
| CC Pharma GmbH · Densborn | 121 | 2022–2025 |
| Orifarm GmbH · Leverkusen | 113 | 2015–2025 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019260
2020167
2021201
2022187
2023291
2024654
20251,183
20259
2026739
Who knows the rhythm prepares instead of reacting.
169
days until the deadline — Friday 5 February at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →